These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6254886)

  • 1. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.
    Donnenberg AD; Chaikof E; Aurelian L
    Infect Immun; 1980 Oct; 30(1):99-109. PubMed ID: 6254886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
    Donnenberg AD; Bell RB; Aurelian L
    Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors.
    Iwasaka T; Sheridan JF; Aurelian L
    Infect Immun; 1983 Dec; 42(3):955-64. PubMed ID: 6227561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
    Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
    J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.
    Sheridan JF; Aurelian L; Donnenberg AD; Quinn TC
    J Clin Immunol; 1984 Jul; 4(4):304-11. PubMed ID: 6086703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
    Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity in herpetic keratitis measured by leukocyte migration inhibition.
    Polack FM; Habash N; Zam ZS; Burdette MG
    Ann Ophthalmol; 1982 Sep; 14(9):825-7. PubMed ID: 6295252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
    Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
    J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
    Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
    Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro.
    Sheridan JF; Beck M; Smith CC; Aurelian L
    J Immunol; 1987 Feb; 138(4):1234-9. PubMed ID: 3027176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
    Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E
    J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal studies on the efficacy of vaccination against recurrent herpes.
    Scriba M
    Med Microbiol Immunol; 1982; 171(1):33-42. PubMed ID: 6289061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.
    Aurelian L; Smith CC; Wachsman M; Paoletti E
    Rev Infect Dis; 1991; 13 Suppl 11():S924-34. PubMed ID: 1664130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
    Cunningham AL; Noble JR
    J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.